Meanwhile, altered expression levels of DDR‐related genes (such as POLQ and p53) significantly enhance DNA repair capacity or disrupt cell cycle checkpoint function, ultimately leading to decreased tumor cell sensitivity to chemotherapeutic agents. Here, TP53 is linked to neoplasm.